Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,570 | -27,816 | -28,323 | -28,669 | -30,699 |
| Depreciation Amortization | 560 | 936 | 929 | 1,604 | 1,879 |
| Accounts receivable | -172 | 186 | -956 | -1,424 | 1,996 |
| Other Working Capital | -2,084 | 1,539 | 353 | -5,629 | -877 |
| Other Operating Activity | 6,059 | 1,702 | 5,388 | 8,318 | 5,341 |
| Operating Cash Flow | $-38,207 | $-23,453 | $-22,609 | $-25,800 | $-22,360 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -176 | N/A | N/A | N/A | -32 |
| Purchase Sale Intangibles | -66 | N/A | N/A | N/A | -561 |
| Other Investing Activity | -66 | 0 | 0 | 0 | -561 |
| Investing Cash Flow | $-242 | $N/A | $N/A | $N/A | $-593 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 7,273 | N/A |
| Debt Repayment | -290 | -2,560 | -912 | -44 | N/A |
| Common Stock Issued | 42,444 | 62,151 | 2,668 | 263 | 6,433 |
| Other Financing Activity | -1,016 | -4,895 | 0 | -461 | -485 |
| Financing Cash Flow | $41,138 | $54,696 | $1,756 | $7,031 | $5,948 |
| Exchange Rate Effect | 2,122 | -2,544 | 549 | -1,866 | 244 |
| Beginning Cash Position | 54,912 | 26,213 | 46,517 | 67,152 | 83,913 |
| End Cash Position | 59,723 | 54,912 | 26,213 | 46,517 | 67,152 |
| Net Cash Flow | $4,811 | $28,699 | $-20,304 | $-20,635 | $-16,761 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,207 | -23,453 | -22,609 | -25,800 | -22,360 |
| Capital Expenditure | -176 | N/A | N/A | N/A | -32 |
| Free Cash Flow | -38,383 | -23,453 | -22,609 | -25,800 | -22,392 |